Investing
Stock

Economy
Politics

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by June 4, 2025

by June 4, 2025 0 comment

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0 comment

0

Facebook Twitter Pinterest Email

previous post

5 Biggest Blockchain ETFs in 2025

next post

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

You may also like

Valeura Energy Inc. Announces Thailand to Prioritise Domestic...

March 3, 2026

Vale CEO: Real Assets Gaining Traction as Money...

March 3, 2026

Outstanding Antimony Results at Casablanca

March 3, 2026

High-Grade Antimony Assays Confirm Surface Continuity at DAM

March 3, 2026

Bold Ventures Signs Agreement to Acquire 6 Key...

March 2, 2026

New Found Gold Grade Control Drilling Continues to...

March 2, 2026

Closing date for director nominations

March 2, 2026

Bold Ventures Provides Update on Burchell Drilling Progress...

March 1, 2026

Kevin Wadsworth, Patrick Karim: Gold, Silver Price Targets,...

February 28, 2026

55 North Mining Announces Closing of Flow-Through Financing

February 28, 2026

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Categories

Economy (316)
Investing (1,323)
Politics (1,661)
Stock (272)

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 financeblueocean.com | All Rights Reserved

Investing
Stock

Economy
Politics